Africa's First End-to-End Multi-Vaccine Manufacturing Facility
Sector: Manufacturing (Industrial) • Location: Johannesburg, South Africa
Source: Devdiscourse
A multi-vaccine manufacturing facility in South Africa anchored by Biovac, aimed at strengthening vaccine sovereignty in Africa and addressing global supply gaps. The facility will produce oral cholera vaccines initially, then expand to polio, pneumonia, and meningitis vaccines, with an annual production capacity of 30-40 million doses.
- Status
- Prospective
- Sector
- Manufacturing (Industrial)
- Location
- Johannesburg, South Africa
- Updated
- 22 Jul 2026
- Source
- Devdiscourse
ConstructChat
Ask ConstructChat about Africa's First End-to-End Multi-Vaccine Manufacturing Facility
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
| Not available for this record. |
Status
Original status | planned |
Taiyo status | Prospective |
Taiyo last update | 2026-07-22 |
Contact
| Not available for this record. |
Description
Description | A multi-vaccine manufacturing facility in South Africa anchored by Biovac, aimed at strengthening vaccine sovereignty in Africa and addressing global supply gaps. The facility will produce oral cholera vaccines initially, then expand to polio, pneumonia, and meningitis vaccines, with an annual production capacity of 30-40 million doses. |
Original sector | Health |
Budget |
Location
Country | South Africa |
City | Johannesburg |
Source
Source | Devdiscourse |
URL |
More Details
Record type | Project |
Sector | Manufacturing (Industrial) |
Article published date | 2026-04-20 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project